🇺🇸 FDA
Pipeline program

Subcutaneous depot medroxyprogesterone acetate

Pro00012433

Approved small_molecule completed

Quick answer

Subcutaneous depot medroxyprogesterone acetate for Contraception is a Approved program (small_molecule) at Protara Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Protara Therapeutics
Indication
Contraception
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials